Shin Y

ORCID: 0009-0006-8626-0285 · 6 papers in corpus
observational 2026
Clinical pharmacology and therapeutics ·doi:10.1002/cpt.70136

Despite widespread rhFSH use in infertile women undergoing ART, real-world comparative data on its effectiveness and safety across different rhFSH types remain limited. Using the HIRA claims database, we included 10,684 women aged 20-39 wit…

review 2026
Advanced materials (Deerfield Beach, Fla.) ·doi:10.1002/adma.202520454

Women's health remains inadequately served due to the historical predominance of males as the biological reference in medical research, leading to persistent sex-based gaps in the understanding, diagnosis, and management of disease. As heal…

lab-animal 2025
Nature communications ·doi:10.1038/s41467-025-57323-6

Cervical cancer is the fourth most common female cancer, with the uterine ectocervix being the most commonly affected site. However, cervical stem cells, their differentiation, and their regulation remain poorly understood. Here, we report …

observational 2024
Journal of menopausal medicine ·doi:10.6118/jmm.24014

OBJECTIVES: This study aimed to investigate the risk of osteoarthritis associated with menopausal hormone therapy (MHT). METHODS: This population-based retrospective cohort study used a database of Korean health insurance claims (2007-2020…

review 2022
Cells ·doi:10.3390/cells11040650

Aggressive and recurrent gynecological cancers are associated with worse prognosis and a lack of effective therapeutic response. Ovarian cancer (OC) patients are often diagnosed in advanced stages, when drug resistance, angiogenesis, relaps…

2017
BMC complementary and alternative medicine